Abstract
Recent studies have shown that testosterone induces relaxation of different arteries, although the mechanism of this action is still under debate. We investigated the involvement of potassium channels in this mechanism. Using standard organ bath techniques, rings of human umbilical arteries (HUA) without endothelium were contracted by serotonin (5-HT, 1 μM), histamine (10 μM) and potassium chloride (KCl, 30 and 60 mM), and the vasorelaxant effect of testosterone was analysed. Testosterone (100 μM) relaxed human umbilical arteries contracted with 5-HT (30.1 ± 3.2%), histamine (55.1 ± 2.6%), KCl 30 mM (52.9 ± 8.3%) and KCl 60 mM (54.8 ± 6.3%). Flutamide (10 μM), an inhibitor of classical intracellular testosterone receptor, and glibenclamide, an ATP-sensitive potassium-channels (KATP) inhibitor, did not influence the testosterone relaxant effect. 4-aminopyridine, a voltage-sensitive potassium-channels (Kv) inhibitor, decreased the effect of testosterone on histamine- and 5-HT-contracted arteries. Tetraethylammonium (TEA), which inhibits Kv channels and large-conductance Ca2+-activated potassium channels (BKCa), decreased the effect of testosterone on KCl (60 mM)-contracted and 5-HT-contracted HUA. In conclusion, testosterone induces relaxation of HUA, and this effect does not appear to be mediated via a classic intracellular testosterone receptor-dependent mechanism. Our results suggest that this relaxation is partially mediated by activation of BKCa and KV channels. The involvement of these two channels in testosterone-relaxant mechanism is dependent on the pathways activated by the contractile agent used.
Similar content being viewed by others
References
Alexandersen P, Haarbo J, Christiansen C (1996) The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 125:1–13
Bae YM, Kim A, Kim J, Park SW, Kim TK, Lee YR, Kim B, Cho SI (2006) Serotonin depolarizes the membrane potential in rat mesenteric artery myocytes by decreasing voltage-gated K+ currents. Biochem Biophys Res Commun 347:468–476
Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K (1996) Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94:2614–2619
Cogolludo A, Moreno L, Lodi F, Frazziano G, Cobeno L, Tamargo J, Perez-Vizcaino F (2006) Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization. Circ Res 98:931–938
Crews JK, Khalil RA (1999) Antagonistic effects of 17 beta-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 19:1034–1040
Deenadayalu VP, White RE, Stallone JN, Gao X, Garcia AJ (2001) Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol 281:H1720–H1727
Ding AQ, Stallone JN (2001) Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation. J Appl Physiol 91:2742–2750
English KM, Jones RD, Jones TH, Morice AH, Channer KS (2000a) Aging reduces the responsiveness of coronary arteries from male Wistar rats to the vasodilatory action of testosterone. Clin Sci (Lond) 99:77–82
English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS (2000b) Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 21:890–894
English KM, Steeds RP, Jones TH, Diver MJ, Channer KS (2000c) Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102:1906–1911
Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M (2000) Multiple actions of steroid hormones–a focus on rapid, nongenomic effects. Pharmacol Rev 52:513–556
Fausett MB, Belfort MA, Nanda R, Saade GR, Vedernikov Y (1999) The effects of sex steroids on human umbilical artery and vein. J Soc Gynecol Investig 6:27–31
Gerulewicz-Vannini D, Camero Y, Salas J, Hernandez-Andrade E (2006) [High plasmatic androgen levels in women affected with pregnancy-induced hypertension]. Rev Invest Clin 58:228–233
Hall J, Jones RD, Jones TH, Channer KS, Peers C (2006) Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 147:2675–2680
Hawley J, Rubin PC, Hill SJ (1995) Distribution of receptors mediating phosphoinositide hydrolysis in cultured human umbilical artery smooth muscle and endothelial cells. Biochem Pharmacol 49:1005–1011
Honda H, Unemoto T, Kogo H (1999) Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension 34:1232–1236
Jahnichen S, Glusa E, Pertz HH (2005) Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs. Naunyn Schmiedebergs Arch Pharmacol 371:89–98
Jarajapu YP, Oomen C, Uteshev VV, Knot HJ (2006) Histamine decreases myogenic tone in rat cerebral arteries by H2-receptor-mediated KV channel activation, independent of endothelium and cyclic AMP. Eur J Pharmacol 547:116–124
Jones RD, English KM, Pugh PJ, Morice AH, Jones TH, Channer KS (2002) Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. J Cardiovasc Pharmacol 39:814–823
Jones RD, English KM, Jones TH, Channer KS (2004) Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action. Clin Sci (Lond) 107:149–158
Leung SW, Quan A, Lao TT, Man RY (2006) Efficacy of different vasodilators on human umbilical arterial smooth muscle under normal and reduced oxygen conditions. Early Hum Dev 82:457–462
Lovren F, Li XF, Lytton J, Triggle C (1999) Functional characterization and m-RNA expression of 5-HT receptors mediating contraction in human umbilical artery. Br J Pharmacol 127:1247–1255
Malkin CJ, Jones RD, Jones TH, Channer KS (2006) Effect of testosterone on ex vivo vascular reactivity in man. Clin Sci (Lond) 111:265–274
Murphy JG, Khalil RA (1999) Decreased [Ca2+]i during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther 291:44–52
Orshal JM, Khalil RA (2004) Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286:R233–R249
Pasqualini JR (2005) Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol 97:401–415
Pauwels PJ (2000) Diverse signalling by 5-hydroxytryptamine (5-HT) receptors. Biochem Pharmacol 60:1743–1750
Perusquia M, Villalon CM (1999) Possible role of Ca2+ channels in the vasodilating effect of 5beta-dihydrotestosterone in rat aorta. Eur J Pharmacol 371:169–178
Perusquia M, Hernandez R, Morales MA, Campos MG, Villalon CM (1996) Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta. Gen Pharmacol 27:181–185
Pinthus JH, Trachtenberg J, Klotz L (2006) Cardiovascular effects of androgen depletion and replacement therapy. Urology 67:1126–1132
Quan A, Leung SW, Lao TT, Man RY (2003) 5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure. J Soc Gynecol Investig 10:490–495
Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G (2006) Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol 126:16–19
Schneider A, Riess P, Elbers A, Neugebauer E, Schaefer U (2004) Polyclonal anti-histamine H2 receptor antibodies detect differential expression of H2 receptor protein in primary vascular cell types. Inflamm Res 53:223–229
Scragg JL, Jones RD, Channer KS, Jones TH, Peers C (2004) Testosterone is a potent inhibitor of L-type Ca2+ channels. Biochem Biophys Res Commun 318:503–506
Steinert JR, Wyatt AW, Poston L, Jacob R, Mann GE (2002) Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells. FASEB J 16:721–723
Tammaro P, Smith AL, Hutchings SR, Smirnov SV (2004) Pharmacological evidence for a key role of voltage-gated K+ channels in the function of rat aortic smooth muscle cells. Br J Pharmacol 143:303–317
Tep-areenan P, Kendall DA, Randall MD (2002) Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol 135:735–740
Tep-areenan P, Kendall DA, Randall MD (2003) Mechanisms of vasorelaxation to testosterone in the rat aorta. Eur J Pharmacol 465:125–132
Terron JA, Falcon-Neri A (1999) Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br J Pharmacol 127:609–616
Tufan H, Ayan-Polat B, Tecder-Unal M, Polat G, Kayhan Z, Ogus E (2003) Contractile responses of the human umbilical artery to KCl and serotonin in Ca-free medium and the effects of levcromakalim. Life Sci 72:1321–1329
Won E, Won J, Kwon S, Lee Y, Nam T, Ahn D (2003) Testosterone causes simultaneous decrease of [Ca2+]i and tension in rabbit coronary arteries: by opening voltage dependent potassium channels. Yonsei Med J 44:1027–1033
Yildiz O, Seyrek M, Gul H, Un I, Yildirim V, Ozal E, Uzun M, Bolu E (2005) Testosterone relaxes human internal mammary artery in vitro. J Cardiovasc Pharmacol 45:580–585
Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P (1995) Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91:1154–1160
Acknowledgements
We thank the donor mothers and the Gynaecology-Obstetrics Department staff of Centro Hospitalar da Cova da Beira (Covilhã, Portugal) for their collaboration and the Fundação para a Ciência e a Tecnologia (Portugal) for supporting the fellowship grants SFRH/BPD/14458/2003 and SFRH/BDE/15532/2004.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cairrão, E., Álvarez, E., Santos-Silva, A.J. et al. Potassium channels are involved in testosterone-induced vasorelaxation of human umbilical artery. Naunyn-Schmied Arch Pharmacol 376, 375–383 (2008). https://doi.org/10.1007/s00210-007-0213-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-007-0213-3